Decoy Therapeutics (DCOY)
NASDAQ:DCOY
Want to see DCOY full AI Analyst Report?
Decoy Therapeutics (DCOY) Ownership Overview
The ownership structure of Decoy Therapeutics (DCOY) stock is a mix of institutional, retail, and individual investors. , 4.73% is owned by Insiders, and 95.26% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jan 02, 2026 | xxxxxxxxxxxxx | $17 | |
Nov 24, 2025 | xxxxxxxxxxxxx | $3700 | |
Nov 20, 2025 | xxxxxxxxxxxxx | $16000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 20,177 | Insider | 3.79% | 119,044 | |
| 5,000 | Insider | 0.94% | 29,500 | |
| 20 | Institution | <0.01% | 118 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 20 | Institution | <0.01% | 126 |
FAQ
Who Owns Decoy Therapeutics (DCOY)?
Currently, no data Available
What percentage of Decoy Therapeutics (DCOY) stock is held by institutional investors?
Currently, no data Available
What percentage of Decoy Therapeutics (DCOY) stock is held by retail investors?
According to the latest TipRanks data, approximately 95.26% of Decoy Therapeutics (DCOY) stock is held by retail investors.
Who owns the most shares of Decoy Therapeutics (DCOY)?
Mark J. Rosenblum owns the most shares of Decoy Therapeutics (DCOY).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.